Get my own profile
Public access
View all12 articles
1 article
available
not available
Based on funding mandates
Co-authors
- Jason ColeDeputy Director, CCDCVerified email at ccdc.cam.ac.uk
- Robin TaylorEmeritus Research Fellow, Cambridge Crystallographic Data CentreVerified email at justmagnolia.co.uk
- Marcel VerdonkVerified email at verdonk.co.uk
- Jonathan BaellExecutive Director Early Leads Chemistry, Lyterian TherapeuticsVerified email at lyterian.com
- Richard D TaylorDirector, CADD, UCBVerified email at ucb.com
- Jayme L DahlinBrigham and Women's HospitalVerified email at bwh.harvard.edu
- Michael A. WaltersUniversity of MinnesotaVerified email at umn.edu
- Sylvie GuichardDirector Translational Science Forma TherapeuticsVerified email at astrazeneca.com
- Philip JewsburyAstraZeneca PharmaceuticalsVerified email at wasabi1.plus.com
- Willem VerboomAssociate professor of chemistry, University of TwenteVerified email at utwente.nl
- Gianni ChessariVP Chemistry @ Astex PharmaceuticalsVerified email at astx.com
- Michal BistaCaptor TherapeuticsVerified email at captortherapeutics.com
- James S ScottAstraZenecaVerified email at astrazeneca.com
- William DuddyUniversity of UlsterVerified email at ulster.ac.uk
- Ian HicksonCRUK Newcastle Drug Discovery Unit, Newcastle UniversityVerified email at newcastle.ac.uk
- Gerhard KlebeProfessor für Pharmazeutische Chemie, Philipps-UniversitätVerified email at mailer.uni-marburg.de